Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers

International Journal of Pharmaceutics

Volumn 496, Issue 2, 2015, Pages 976-983

  El Salamouni, Noha S ^a   Farid, Ragwa M ^a   El Kamel, Amal H ^b   El Gamal, Safaa S ^b  

^a Pharos University in Alexandria   (Egypt)

^b Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Autoclaving; Brimonidine; Glaucoma; Nanostructured lipid carriers; Ocular; Solid lipid nanoparticles

Indexed keywords

BRIMONIDINE; GLYCEROL STEARATE; NANOCARRIER; NANOMATERIAL; SOLID LIPID NANOPARTICLE; DRUG CARRIER; LIPID; NANOPARTICLE;

ARTICLE; AUTOCLAVE; DRUG FORMULATION; DRUG STABILITY; INSTRUMENT STERILIZATION; MORPHOLOGY; PARTICLE SIZE; PRIORITY JOURNAL; TEMPERATURE; ZETA POTENTIAL; CHEMISTRY; MEDICINAL CHEMISTRY; VISCOSITY;

BRIMONIDINE TARTRATE; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; LIPIDS; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; STERILIZATION; VISCOSITY;

EID: 84949556196     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.10.043     Document Type: Article

References (46)

1. A.A. Attama, B.C. Schicke, T. Paepenmüller, and C.C. Müller-Goymann Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization Eur. J. Pharm Biopharm. 67 1 2007 48 57
2. R.H. Müller, W. Mehnert, J.S. Lucks, C. Schwarz, A. Zur Mühlen, H. Meyhers, and et al. Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery Eur. J. Pharm. Biopharm. 41 1 1995 62 69
3. R. Cavalli, M.R. Gasco, P. Chetoni, S. Burgalassi, and M.F. Saettone Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin Int. J. Pharm. 238 1 2002 241 245
4. A.A. Attama, S. Reichl, and C.C. Müller-Goymann Diclofenac sodium delivery to the eye: In vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct Int. J. Pharm. 355 1 2008 307 313
5. E.H. Gokce, G. Sandri, M.C. Bonferoni, S. Rossi, F. Ferrari, T. Güneri, A. Cyclosporine, and et al. loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity Int. J. Pharm. 364 1 2008 76 86
6. R.H. Müller, R.D. Petersen, A. Hommoss, and J. Pardeike Nanostructured lipid carriers (NLC) in cosmetic dermal products Adv. Drug Deliv. Rev. 59 6 2007 522 530
7. R.H. Müller, M. Radtke, and S.A. Wissing Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 2002 S131 S155
8. E. Gonzalez-Mira, M.A. Egea, E.B. Souto, A.C. Calpena, and M.L. Garcia Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery Nanotechnology 22 4 2011 1 15
9. R.H. Müller, M. Radtke, and S.A. Wissing Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 1 2002 121 128
10. B. Tian, Q. Luo, S. Song, D. Liu, H. Pan, W. Zhang, and et al. Novel surface modified nanostructured lipid carriers with partially deacetylated water soluble chitosan for efficient ocular delivery J. Pharm. Sci. 101 3 2012 1040 1049
11. A.A. Acheampong, M. Shackleton, B. John, J. Burke, L.A. Wheeler, and D. Tang-Liu Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes Drug Metab. Dispos. 30 4 2002 421 429
12. L.B. Cantor, D. WuDunn, Y. Catoira-Boyle, and C.W. Yung Absorption of brimonidine 0.1% and 0.15% ophthalmic solutions in the aqueous humor of cataract patients J. Glaucoma 17 7 2008 529 534
13. R.J. Noecker The management of glaucoma and intraocular hypertension: current approaches and recent advances Ther. Clin. Risk Manag. 2 2 2006 193 205
14. P. Dipti, M.M. Patel, N.M. Patel, and P. Manish Preparation and evaluation of ocular inserts containing Brimonidine tartrate IJPCR 1 2009 19 22
15. H.B.D. Biner, M. Mroz, A.M. Shapiro, and M.S. Dirks A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial Clin. Ther. 23 12 2001 1969 1983
16. W. Mehnert, and K. Mäder Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 2 2001 165 196
17. J.P. Sculier, A. Coune, C. Brassinne, C. Laduron, G. Atassi, J.M. Ruysschaert, and et al. Intravenous infusion of high doses of liposomes containing NSC 251635, a water-insoluble cytostatic agent. A pilot study with pharmacokinetic data J. Clin. Oncol. 4 5 1986 789 797
18. Sterilization of drug-free and tetracaine-loaded solid lipid nanoparticles (SLN) C. Schwarz, and W. Mehnert Proc First World Meeting APGI/APV Budapest 1995
19. Sterilization and Physical Stability of Drug-free and Etomidate-loaded Solid Lipid Nanoparticles C. Schwarz, C. Freitas, W. Mehnert, and R.H. Muller 1995 Proc. Int. Symp. Control Release Bioact. Mater.
20. R.H. Muéller, K. Maéder, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 1 2000 161 177
21. H. Heiati, R. Tawashi, and N.C. Phillips Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization J. Microencapsul. 15 2 1998 173 184
22. Gasco M., Saettone M., Zara G. Pharmaceutical compositions suitable for the treatment of ophthalmic diseases. Google Patents; 2003.
23. J. Youshia, A.O. Kamel, A.E. Shamy, and S. Mansour Design of cationic nanostructured heterolipid matrices for ocular delivery of methazolamide Int. J. Nanomed. 7 2012 2483 2496
24. J. Pardeike, S. Weber, N. Matsko, and A. Zimmer Formation of a physical stable delivery system by simply autoclaving nanostructured lipid carriers (NLC) Int. J. Pharm. 439 1 2012 22 27
25. D.M.A.M. Luykx, R.J.B. Peters, R. Van, S.M. uth, and H. Bouwmeester A review of analytical methods for the identification and characterization of nano delivery systems in food J. Agric. Food Chem. 56 18 2008 8231 8247
26. R. Liu, Z. Liu, C. Zhang, and B. Zhang Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: Improving in vivo ocular bioavailability J. Pharm. Sci. 101 10 2012 3833 3844
27. Y. Sangsen, K. Likhitwitayawuid, B. Sritularak, K. Wiwattanawongsa, and R. Wiwattanapatapee Novel Solid Lipid Nanoparticles for Oral Delivery of Oxyresveratrol: Effect of the Formulation Parameters on the Physicochemical Properties and in vitro Release Int. J. Med. Pharm. Sci. Eng. 7 12 2013 506 513
28. X. Lin, X. Li, L.Q. Zheng, L. Yu, Q. Zhang, and W. Liu Preparation and characterization of monocaprate nanostructured lipid carriers Colloids Surf A Physicochem. Eng. Asp. 311 1 2007 106 111 1
29. J. Li, X. Guo, Z. Liu, C.I. Okeke, N. Li, H. Zhao, and et al. Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies Drug Dev. Ind. Pharm. 0 2013 1 8
30. Z. Liu, X. Zhang, H. Wu, J. Li, L. Shu, R. Liu, and et al. Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo Drug Dev. Ind. Pharm. 37 4 2011 475 481
31. M.A. Kalam, Y. Sultana, A. Ali, M. Aqil, A.K. Mishra, and K. Chuttani Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system J. Drug Target 18 3 2010 191 204
32. J.H. Draize, G. Woodard, and H.O. Calvery Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes J. Pharmacol. Exp. Ther. 82 3 1944 377 390
33. M.S. Ali, A.R. Khatri, M.I. Munir, and M. Ghori A stability-indicating assay of Brimonidine tartrate ophthalmic solution and stress testing using HILIC Chromatographia 70 3-4 2009 539 544
34. L. Kvapil, M. Grepl, and P. Hradil Potential impurity in brimonidine - their synthesis and mass spectrometry identification Acta Univ. Palacki Olomuc. Fac. Rer. Nat. Chem. 42 2003 19 26
35. R. Cavalli, O. Caputo, M.E. Carlotti, M. Trotta, C. Scarnecchia, and M.R. Gasco Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles Int. J. Pharm. 148 1 1997 47 54
36. A.P. Nayak, W. Tiyaboonchai, S. Patankar, B. Madhusudhan, and E.B. Souto Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment Colloids Surf B. Biointerfaces 81 1 2010 263 273
37. R.P. Gullapalli, and B.B. Sheth Influence of an optimized non-ionic emulsifier blend on properties of oil-in-water emulsions Eur. J. Pharm. Biopharm. 48 3 1999 233 238
38. K. Vivek, H. Reddy, and R.S.R. Murthy Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles AAPS PharmSciTech 8 4 2007 16 24
39. J. Araújo, S. Nikolic, M.A. Egea, E.B. Souto, and M.L. Garcia Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye Colloids Surf B Biointerfaces 88 1 2011 150 157
40. G. Wörle, B. Siekmann, M.H.J. Koch, and H. Bunjes Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions Eur. J. Pharm. Sci. 27 1 2006 44 53
41. R. O'laughlin, C. Sachs, H. Brittain, and E. Cohen Effects of variations in physicochemical properties of glyceryl monostearate on the stability of an oil-in-water cream J. Soc. Cosmet Chem. 40 1989 215 229
42. F.Q. Hu, S.P.J.Y. Du, Z.H. Yuan, Y.Q. Ye, and S. Zeng Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system Colloids Surf B Biointerfaces 45 3 2005 167 173
43. L.J. Jia, D.R. Zhang, Z.Y. Li, F.F. Feng, Y.C. Wang, W.T. Dai, and et al. Preparation and characterization of silybin-loaded nanostructured lipid carriers Drug Deliv 17 1 2010 11 18
44. J.Y. Fang, C.L. Fang, C.H. Liu, and Y.H. Su Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC) Eur J Pharm Biopharm 70 2 2008 633 640
45. C. Le Bourlais, L. Acar, H. Zia, P.A. Sado, T. Needham, and R. Leverge Ophthalmic drug delivery systems-recent advances Prog Retin Eye Res 17 1 1998 33 58
46. I.D. Rupenthal, C.R. Green, and R.G. Alany Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: Physicochemical characterisation and in vitro release Int. J. Pharm. 77 2011 1